Oberweis Asset Management Inc. Boosts Holdings in Encompass Health Co. (NYSE:EHC)

Oberweis Asset Management Inc. lifted its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 11.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 340,829 shares of the company's stock after buying an additional 34,221 shares during the period. Encompass Health comprises 1.5% of Oberweis Asset Management Inc.'s portfolio, making the stock its 6th biggest holding. Oberweis Asset Management Inc. owned approximately 0.34% of Encompass Health worth $31,476,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its position in Encompass Health by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company's stock worth $960,817,000 after purchasing an additional 138,196 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Encompass Health by 3.3% in the fourth quarter. Invesco Ltd. now owns 5,536,251 shares of the company's stock valued at $511,273,000 after buying an additional 176,135 shares during the last quarter. Alliancebernstein L.P. raised its position in Encompass Health by 6.0% in the 4th quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company's stock worth $191,799,000 after purchasing an additional 117,617 shares during the last quarter. FMR LLC increased its position in Encompass Health by 0.8% in the fourth quarter. FMR LLC now owns 1,973,846 shares of the company's stock worth $182,285,000 after purchasing an additional 15,831 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Encompass Health by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company's stock valued at $155,176,000 after buying an additional 6,164 shares during the period. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Stock Up 1.7 %

Shares of NYSE:EHC traded up $1.98 during trading on Monday, hitting $115.35. 1,228,248 shares of the company were exchanged, compared to its average volume of 677,912. Encompass Health Co. has a fifty-two week low of $82.38 and a fifty-two week high of $115.83. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average price of $100.08 and a two-hundred day moving average price of $98.57. The stock has a market cap of $11.62 billion, a price-to-earnings ratio of 25.86, a P/E/G ratio of 2.31 and a beta of 0.87.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The firm had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company's revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter last year, the company posted $1.12 earnings per share. As a group, research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were given a $0.17 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.59%. Encompass Health's payout ratio is 15.25%.

Wall Street Analyst Weigh In

EHC has been the subject of a number of analyst reports. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Friday. Truist Financial reissued a "buy" rating and set a $135.00 price target (up from $116.00) on shares of Encompass Health in a research report on Monday. Barclays lifted their price target on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Royal Bank of Canada upped their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday. Nine research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.